Art Unit 1618
Group 1610Pharmaceutical and Agricultural Compositions
- Active examiners
- 20
- Average office actions per grant
- 2.53
Grant ratio
- Art Unit 1618
- 44.4%
- Group 1610
- 42.8%
Active examiners
| Paul Dickinson | 58.3% | 2.35 | October 2026 |
|---|---|---|---|
| Micah-Paul Young | 50.1% | 2.59 | October 2026 |
| D. L. Jones | 57.7% | 2.19 | October 2026 |
| Nissa Westerberg | 21.5% | 3.10 | October 2026 |
| James W Rogers | 42.2% | 2.65 | October 2026 |
| Melissa Perreira | 48.0% | 2.58 | October 2026 |
| Jake Vu | 36.7% | 2.79 | October 2026 |
| Jagadishwar Rao Samala | 63.8% | 1.88 | October 2026 |
| Sean R Donohue | 36.3% | 2.76 | October 2026 |
| Robert S Cabral | 60.6% | 2.86 | October 2026 |
| Leah H Schlientz | 36.9% | 2.61 | October 2026 |
| Blessing M. Fubara | 24.6% | 2.12 | October 2026 |
| Kaila A Craig | 14.7% | 2.00 | October 2026 |
| Shirley V. Gembeh | 21.1% | 1.90 | October 2026 |
| Samantha L. Mejias | 4.2% | 1.60 | October 2026 |
| Eric E. Silverman | 31.4% | 2.17 | September 2026 |
| Jong Hwan Baek | 0.0% | N/A | October 2026 |
| Susan Tran | 57.1% | 2.41 | October 2026 |
| James David Burgess | 0.0% | N/A | October 2026 |
| Liliana Cerullo | 0.0% | 1.00 | October 2026 |
Examiner distribution
- Median grant ratio
- 36.7%
- Middle 50% of grant ratios
- 21.5%–50.1%
- Median office actions / grant
- 2.46
- Middle 50% of office actions / grant
- 2.09–2.68
Active examiners with at least 20 applications.
Other associated examiners
Examiners without recent activity.
| Lance Rider | 30.8% | 2.59 | March 2024 Appears inactive |
|---|---|---|---|
| Jennifer Lamberski | 51.6% | 2.99 | August 2025 Appears inactive |
| Nabila Ebrahim | 34.7% | 2.88 | December 2020 Appears inactive |
| Eric E. Silverman | 38.1% | 2.21 | January 2010 Appears inactive |
| Sun Y. Kim | 48.6% | 1.67 | March 2014 Appears inactive |
| Humera N. Sheikh | 77.8% | 2.31 | March 2026 Appears inactive |
| Hasan Ahmed | 0.0% | 2.64 | November 2022 Appears inactive |
Based on available public USPTO records; may be incomplete.